title: Resetting of the sympathetic baroreflex is associated with the onset of hypertension during chronic intermittent hypoxia.
abstract: Chronic intermittent hypoxia (CIH) is a model of arterial hypoxemia that accompanies sleep apnea and increases resting arterial pressure (AP). We examined the effects of 7 days of exposure to CIH on arterial baroreflex control of renal sympathetic nerve activity (RSNA) and heart rate (HR) in rats. Sprague-Dawley rats (15±2 weeks old) were exposed to CIH (9% oxygen for 3 min every 10 min, 8 h per day) for 7 days (n=16) while control rats (n=18) were maintained in normoxia. Baroreflex regulation of RSNA and HR were estimated in Inactin anesthetized and artificially ventilated rats during infusions of phenylephrine and nitroprusside to manipulate AP. After exposure to CIH, resting mean AP was higher in CIH than that in control group (115±7 vs. 105±7, P<0.001). Resting HR did not differ between the two groups. Exposure to CIH shifted the AP-RSNA relationship rightward (approximately 10 mm Hg, P<0.01). CIH did not alter maximum gain of the baroreflex control of RSNA (-2.6±0.6 vs. -2.5±0.6 arbitrary units (a.u.)/mm Hg) and HR (-1.8±0.6 vs. -1.8±0.7 bpm/mm Hg, CIH vs. control). In addition, cardiac spontaneous baroreflex sensitivity in conscious rats (n=8) also did not change during exposure to CIH. These results indicate that resetting of the sympathetic baroreflex control, rather than an impairment of its sensitivity, is associated with an onset of hypertension induced by CIH.
authors.affiliation: Department of Integrative Physiology, Cardiovascular Research Institute, University of North Texas Health Science Centre, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
authors.forename: Kenta
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Wendy
authors.initials: W
authors.lastname: Eubank
authors.forename: Michelle
authors.initials: M
authors.lastname: Franzke
authors.forename: Steve
authors.initials: S
authors.lastname: Mifflin
mesh_terms: D000818:Animals; D001273:Atmosphere Exposure Chambers; D017704:Baroreflex / Q000187:drug effects; D004195:Disease Models, Animal; D006339:Heart Rate / Q000187:drug effects; D006973:Hypertension / Q000209:etiology*; D000860:Hypoxia / Q000209:etiology / Q000503:physiopathology*; D007668:Kidney / Q000098:blood supply / Q000294:innervation; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009599:Nitroprusside / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012119:Respiration / Q000187:drug effects; D012891:Sleep Apnea Syndromes / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
chemical_list: D009599:Nitroprusside; D010656:Phenylephrine